Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life
Rossella De Luca,1 Giuseppe Profita,2 Giuseppe Cicero1 1Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy; 2Department of Surgical, Oncological and Oral Sciences, Section of Surgical, University of Palermo, Palermo, Italy Obje...
Main Authors: | De Luca R, Profita G, Cicero G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/nab-paclitaxel-in-pretreated-metastatic-breast-cancer-evaluation-of-ac-peer-reviewed-article-OTT |
Similar Items
-
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
by: De Luca R, et al.
Published: (2018-06-01) -
Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01) -
Reduction in Circulating Tumor Cell Count following Therapy with nab®-Paclitaxel plus Carboplatin in a Patient with Leptomeningeal Carcinomatosis from Breast Cancer
by: Andrea Stebel
Published: (2012-01-01) -
Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
by: Amir Bahrami-Ahmadi, et al.
Published: (2012-01-01) -
Gelatin Methacryloyl Hydrogels Control the Localized Delivery of Albumin-Bound Paclitaxel
by: Margaux Vigata, et al.
Published: (2020-02-01)